Oct 28, 2025 8:00am EDT bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases
Oct 20, 2025 8:00am EDT bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
Oct 16, 2025 8:00am EDT bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer
Oct 09, 2025 1:00pm EDT bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
Oct 08, 2025 3:45pm EDT bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
Oct 07, 2025 8:00am EDT bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025
Sep 26, 2025 8:00am EDT bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung
